Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A, Bray F. Global Cancer
Statistics 2020: GLOBOCAN Estimates of Incidence
and Mortality Worldwide for 36 Cancers in 185
Countries. CA Cancer J Clin. 2021;71(3):209-249.
2. Bidhendi-Yarandi R, Panahi MH. Trends in Leading
Cancer Incidence among Iranian Women: Annual
Cancer Registry Reports, 2003-2015. Iran J Public
Health. 2021 Aug;50(8):1705-12.
3. Akbari M.E, Akbari A, Khayamzadeh M, Salmanian
R, Akbari M. Ten-Year Survival of Breast Cancer in
Iran: A National Study (Retrospective Cohort Study).
Breast Care 2023;18(1):12–21.
4. Fendereski A, et al. Evaluation of Factors Related to
Short-Term and Long-Term Survival of Breast Cancer
Patients by Mixture Cure Model. Iran J Breast Dis
2022;15(1) :4–17.
5. Kavya N et al. Breast Cancer Lesion Detection from
Cranial-Caudal View of Mammogram Images Using
Statistical and Texture Features Extraction. Int J
Biomed Clin Eng 2020;9(1): 16–32.
6. Ranganathan K, Singh P, Raghavendran K, Wilkins
EG, Hamill JB, Aliu O, Newman LA, Hutton D,
Momoh AO. The Global Macroeconomic Burden of
Breast Cancer: Implications for Oncologic Surgery.
Ann Surg. 2021;274(6):1067-72.
7. Franklin M, Pollard D, Sah J, Rayner A, Sun Y, Dube
F, Sutton A, Qin L. Direct and Indirect Costs of Breast
Cancer and Associated Implications: A Systematic
Review. Adv Ther. 2024;41(7):2700-22.
8. Polgár C, Kahán Z, Ivanov O, Chorváth M, Ligačová
A, Csejtei A, Gábor G, Landherr L, Mangel L, Mayer
Á, Fodor J. Radiotherapy of Breast CancerProfessional Guideline 1st Central-Eastern European
Professional Consensus Statement on Breast Cancer.
Pathol Oncol Res. 2022;28:1610378.
9. Harris EE. R, Small W. Intraoperative Radiotherapy
for Breast Cancer. Front Oncol 2017; 7: 317.
10. Jiao Y, Cao F, Liu H. Radiation-induced Cell Death
and Its Mechanisms. Health Phys 2022; 123(5):376–
86.
11. Tan J, Sun X, Zhao H, Guan H, Gao S, Zhou P.
Double‐strand DNA break repair: molecular
mechanisms and therapeutic targets. MedComm
(2020). 2023 Oct 5;4(5):e388.
12. Yamazaki T, Vanpouille-Box C, Demaria S,
Galluzzi L. Immunogenic Cell Death Driven by
Radiation-Impact on the Tumor Microenvironment.
Cancer Treat Res. 2020;180:281-96.
13. Yang T, Li W, Huang T, Zhou J. Genetic Testing
Enhances the Precision Diagnosis and Treatment of
Breast Cancer. Int J Mol Sci. 2023;24(23):16607.
14. Wang H, Zou W, Cao Y. Radiation-induced cellular
senescence and adaptive response: mechanistic
interplay and implications. Radiat Med Prot
2025;6(3): 132–9.
15. Lagadec C, Vlashi E, Della Donna L, Dekmezian C,
Pajonk F. Radiation‐Induced Reprogramming of
Breast Cancer Cells. Stem Cells 2012; 30(5): 833–44.
16. Stewart-Ornstein J, Iwamoto Y, Miller MA,
Prytyskach MA, Ferretti S, Holzer Ph, et al. p53
dynamics vary between tissues and are linked with
radiation sensitivity. Nat Commun 2021;12(1): 898.
17. Mohamed HRH, Ibrahim MM, Diab A. Induction of
oxidative DNA damage, cell cycle arrest and p53
mediated apoptosis by calcium titanate nanoparticles
in MCF-7 breast cancer cells. Cancer Cell Int 2022;
22(1):355.
18. Santivasi WL, Xia F. Ionizing Radiation-Induced
DNA Damage, Response, and Repair. Antioxid.
Redox Signal 2014;21(2):251–9.
19. Liu P, Lu Z, Liu L, Li R, Liang Z, Shen M, et al.
NOD-like receptor signaling in inflammationassociated cancers: From functions to targeted
therapies. Phytomedicine. 2019;64:152925.
20. Wang F, Ge R, Cai Y, Zhao M, Fang Z, Li J, et al.
Oxidative stress in ARDS: mechanisms and
therapeutic potential. Front Pharmacol. 2025
26;16:1603287.
21. Jiao Y, Cao F, Liu H. Radiation-induced Cell Death
and Its Mechanisms. Health Phys 2022;123(5):376–
86.
22. Chen YJ, Luo SN, Dong L, Liu TT, Shen XZ, Zhang
NP, et al. Interferon regulatory factor family
influences tumor immunity and prognosis of patients with colorectal cancer. J Transl Med. 2021
6;19(1):379.
23. Bai J, Luo Y, Zhang S. Microarray data analysis
reveals gene expression changes in response to
ionizing radiation in MCF7 human breast cancer cells.
Hereditas 2020; 157(1): 37.
24. Zhou J, Chng WJ. Roles of thioredoxin binding
protein (TXNIP) in oxidative stress, apoptosis and
cancer. Mitochondrion 2013;13(3):163–9.
25. Ding R, Ou W, Chen C, Liu Y, Li H, Zhang X, Chai
H, Ding X, Wang Q. Endoplasmic reticulum stress
and oxidative stress contribute to neuronal pyroptosis
caused by cerebral venous sinus thrombosis in rats:
Involvement of TXNIP/peroxynitrite-NLRP3
inflammasome activation. Neurochem Int.
2020;141:104856.
26. Zhang F, Manna S, Pop LM, Chen ZJ, Fu YX,
Hannan R. Type I Interferon Response in RadiationInduced Anti-Tumor Immunity. Semin Radiat Oncol
2020;30(2): 129–38.
27. Yang Q, Ji H, Modarresi Chahardehi A. JAK/STAT
pathway in myocardial infarction: Crossroads of
immune signaling and cardiac remodeling. Mol
Immunol 2025; 186: 206–17.
28. Sabaawy HE, Ryan BM, Khiabanian H, Pine SR.
JAK/STAT of all trades: linking inflammation with
cancer development, tumor progression and therapy
resistance. Carcinogenesis. 2021;42(12):1411-19.
29. Sagkrioti E, Biz GM, Takan I, Asfa S, Nikitaki Z,
Zanni V, Kars RH, Hellweg CE, Azzam EI, Logotheti
S, et al. Radiation Type- and Dose-Specific
Transcriptional Responses across Healthy and
Diseased Mammalian Tissues. Antioxid. 2022;
11(11):2286.
30. Huang KF, Zhang GD, Huang YQ, Diao Y.
Wogonin induces apoptosis and down-regulates
survivin in human breast cancer MCF-7 cells by
modulating PI3K-AKT pathway. Int
Immunopharmacol. 2012;12(2):334-41.
31. Lu Y, Liu B, Liu Y, Yu X, Cheng G. Dual effects of
active ERK in cancer: A potential target for enhancing
radiosensitivity (Review). Oncol. Lett 2020;20(2):
993–1000.
32. Wang Y, Liu Z, Lv Y, Long J, Lu Y, Huang P.
Mechanisms of radioresistance and radiosensitization
strategies for Triple Negative Breast Cancer. Transl.
Oncol 2025; 55:102351.
33. Busato F, Khouzai B. E, Mognato M. Biological
Mechanisms to Reduce Radioresistance and Increase
the Efficacy of Radiotherapy: State of the Art. Int J
Mol Sci 2022;23(18):10211.
34. Zhao Y, Tan F, Zhao J, Zhou S, Luo Y, Gong C.
Targeting the Enhanced Sensitivity of Radiotherapy in
Cancer: Mechanisms, Applications, and Challenges.
MedComm 2025;6: 70202.
35. Deng J, Pan T, Liu Z, McCarthy C, Vicencio JM,
Cao C, et al. The role of TXNIP in cancer: a fine
balance between redox, metabolic, and
immunological tumor control. Br J Cancer
2023;129(12). 12:1877–92. d
36. Totten SP, Im YK, Cepeda Cañedo E, Najyb O,
Nguyen A, Hébert S, et al. STAT1 potentiates
oxidative stress revealing a targetable vulnerability
that increases phenformin efficacy in breast cancer.
Nat Commun. 2021 Jun 3;12(1):3299.
37. Rydenfelt M, Wongchenko M, Klinger B, Yan Y,
Blüthgen N. The cancer cell proteome and
transcriptome predict sensitivity to targeted and
cytotoxic drugs. Life Sci. Alliance
2019;2(4):201900445
مجله علوم پزشکی پارس